Baudax Bio CEO Gerri Henwood's 2021 pay jumps 178% to $1.7M
Baudax Bio reports 2021 executive compensation
By ExecPay News
Published: March 31, 2022
Baudax Bio reported fiscal year 2021 executive compensation information on March 31, 2022.
In 2021, two Baudax Bio executives received on average a compensation package of $1.2M, a 170% increase compared to previous year.
Gerri Henwood, Chief Executive Officer, received $1.7M in total, which increased by 178% compared to 2020. 55% of Henwood's compensation, or $923K, was in stock awards. Henwood also received $90K in option awards, $618K in salary, as well as $44K in other compensation.
Richard S. Casten, Chief Financial Officer, received a compensation package of $822K. 37% of the compensation package, or $308K, was in salary.